| Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer (NCT04696575) | Roswell Park Cancer Institute | 2021-07-02 |
| Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer (NCT04511039) | Roswell Park Cancer Institute | 2021-06-08 |
| Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study (NCT04803630) | Roswell Park Cancer Institute | 2021-05-06 |
| Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03709550) | Roswell Park Cancer Institute | 2021-04-15 |
| Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship (NCT04548193) | Roswell Park Cancer Institute | 2021-04-05 |
| Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma (NCT04682158) | Roswell Park Cancer Institute | 2021-04-01 |
| Nicotine Vapor Specific Sensory Measurement (NCT04533542) | Roswell Park Cancer Institute | 2021-03-10 |
| Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (NCT03851081) | Roswell Park Cancer Institute | 2021-01-21 |
| Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette Smokers (NCT04744285) | Roswell Park Cancer Institute | 2020-12-04 |
| Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening (NCT04635761) | Roswell Park Cancer Institute | 2020-11-30 |
| Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients (NCT04379518) | Roswell Park Cancer Institute | 2020-11-17 |
| Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia (NCT04207190) | Roswell Park Cancer Institute | 2020-10-23 |
| Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy (NCT04502095) | Roswell Park Cancer Institute | 2020-09-02 |
| Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma (NCT04530812) | Roswell Park Cancer Institute | 2020-08-24 |
| Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer (NCT04032418) | Roswell Park Cancer Institute | 2020-08-13 |
| Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases (NCT03965234) | Roswell Park Cancer Institute | 2020-07-16 |
| Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors (NCT04526587) | Roswell Park Cancer Institute | 2020-07-03 |
| Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study (NCT04231539) | Roswell Park Cancer Institute | 2020-02-18 |
| Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer (NCT03735095) | Roswell Park Cancer Institute | 2020-02-12 |
| Episodic Future Thinking and Future Thinking Priming for Smoking Cessation (NCT04297332) | Roswell Park Cancer Institute | 2020-01-01 |
| TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924) | Roswell Park Cancer Institute | 2019-12-27 |
| Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT04097028) | Roswell Park Cancer Institute | 2019-12-20 |
| Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant (NCT03925532) | Roswell Park Cancer Institute | 2019-12-19 |
| Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma (NCT03793907) | Roswell Park Cancer Institute | 2019-12-17 |
| Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer (NCT04081389) | Roswell Park Cancer Institute | 2019-12-06 |
| Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer (NCT04073745) | Roswell Park Cancer Institute | 2019-12-04 |
| Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation (NCT03881735) | Roswell Park Cancer Institute | 2019-12-02 |
| Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery (NCT03899987) | Roswell Park Cancer Institute | 2019-11-29 |
| Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer (NCT04068649) | Roswell Park Cancer Institute | 2019-11-18 |
| Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer (NCT04110249) | Roswell Park Cancer Institute | 2019-09-06 |
| Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening (NCT04607291) | Roswell Park Cancer Institute | 2019-09-01 |
| Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03751436) | Roswell Park Cancer Institute | 2019-08-02 |
| Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer (NCT03727061) | Roswell Park Cancer Institute | 2019-07-10 |
| CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma (NCT03727789) | Roswell Park Cancer Institute | 2019-07-01 |
| Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers (NCT03897530) | Roswell Park Cancer Institute | 2019-06-30 |
| Palliative Management of Inoperable Malignant Bowel Obstruction (NCT04027348) | Roswell Park Cancer Institute | 2019-06-26 |
| Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy (NCT03935347) | Roswell Park Cancer Institute | 2019-06-20 |
| Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors (NCT03879694) | Roswell Park Cancer Institute | 2019-06-17 |
| Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin (NCT03736720) | Roswell Park Cancer Institute | 2019-06-17 |
| Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers (NCT04060446) | Roswell Park Cancer Institute | 2019-06-06 |
| Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic Surgeries (NCT04000581) | Roswell Park Cancer Institute | 2019-05-31 |
| Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer (NCT03880422) | Roswell Park Cancer Institute | 2019-05-02 |
| Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors (NCT03751449) | Roswell Park Cancer Institute | 2019-03-25 |
| Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer (NCT04067830) | Roswell Park Cancer Institute | 2019-03-20 |
| Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03691376) | Roswell Park Cancer Institute | 2019-03-08 |
| Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice (NCT04297384) | Roswell Park Cancer Institute | 2019-02-06 |
| Web-Based Lifestyle Intervention for the Improvement of Health in African American Cancer Survivors (NCT04290962) | Roswell Park Cancer Institute | 2019-01-17 |
| A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity (NCT03789877) | Roswell Park Cancer Institute | 2019-01-16 |
| Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer (NCT03599453) | Roswell Park Cancer Institute | 2019-01-09 |
| Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients (NCT03895918) | Roswell Park Cancer Institute | 2019-01-03 |
| rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers (NCT03865472) | Roswell Park Cancer Institute | 2018-11-10 |
| Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects (NCT03897270) | Roswell Park Cancer Institute | 2018-10-25 |
| Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-AC (NCT03567850) | Roswell Park Cancer Institute | 2018-10-19 |
| Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy (NCT03457142) | Roswell Park Cancer Institute | 2018-09-11 |
| Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers (NCT03630601) | Roswell Park Cancer Institute | 2018-06-28 |
| Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy (NCT03574792) | Roswell Park Cancer Institute | 2018-05-03 |
| Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT03403634) | Roswell Park Cancer Institute | 2018-04-19 |
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT03358719) | Roswell Park Cancer Institute | 2018-03-27 |
| Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer (NCT03090412) | Roswell Park Cancer Institute | 2018-03-07 |
| Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery (NCT03384836) | Roswell Park Cancer Institute | 2018-01-31 |
| Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer (NCT03348748) | Roswell Park Cancer Institute | 2017-12-18 |
| Mindfulness-Based Stress Reduction in Helping Participants With Metastatic Breast Cancer (NCT03683147) | Roswell Park Cancer Institute | 2017-12-13 |
| Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03017131) | Roswell Park Cancer Institute | 2017-12-08 |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02833506) | Roswell Park Cancer Institute | 2017-12-08 |
| Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer (NCT03211416) | Roswell Park Cancer Institute | 2017-12-07 |
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486) | Roswell Park Cancer Institute | 2017-12-07 |
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer (NCT03297489) | Roswell Park Cancer Institute | 2017-11-06 |
| Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers (NCT04484532) | Roswell Park Cancer Institute | 2017-10-17 |
| Exercise in Improving Health and Quality of Life in Breast Cancer Survivors (NCT03679559) | Roswell Park Cancer Institute | 2017-10-06 |
| Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397) | Roswell Park Cancer Institute | 2017-08-09 |
| Art in Improving Outcomes in Participants Undergo Surgery (NCT03688945) | Roswell Park Cancer Institute | 2017-08-07 |
| Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 (NCT02650986) | Roswell Park Cancer Institute | 2017-07-14 |
| Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation (NCT02953457) | Roswell Park Cancer Institute | 2017-06-29 |
| Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer (NCT02947386) | Roswell Park Cancer Institute | 2017-06-29 |
| Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03685695) | Roswell Park Cancer Institute | 2017-06-27 |
| Talking Pictures Social Media Intervention in Reducing Depressive Symptoms and Improving Spiritual Well-Being and Quality of Life in Adolescent and Young Adult Cancer Patients (NCT03679585) | Roswell Park Cancer Institute | 2017-05-31 |
| SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy (NCT02334865) | Roswell Park Cancer Institute | 2017-04-13 |
| Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer (NCT02965976) | Roswell Park Cancer Institute | 2016-12-30 |
| CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer (NCT02955290) | Roswell Park Cancer Institute | 2016-12-22 |
| Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy (NCT02857374) | Roswell Park Cancer Institute | 2016-11-03 |
| Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02853318) | Roswell Park Cancer Institute | 2016-09-01 |
| Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT02713373) | Roswell Park Cancer Institute | 2016-08-05 |
| Informational Intervention in Increasing Lactation Practices by African American Women (NCT03680235) | Roswell Park Cancer Institute | 2016-07-11 |
| Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism (NCT03011736) | Roswell Park Cancer Institute | 2016-05-12 |
| Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers (NCT02575885) | Roswell Park Cancer Institute | 2016-03-16 |
| Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines (NCT02432378) | Roswell Park Cancer Institute | 2015-09-04 |
| Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT01971489) | Roswell Park Cancer Institute | 2015-09-01 |
| Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy (NCT02452463) | Roswell Park Cancer Institute | 2015-06-29 |
| Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors (NCT02399215) | Roswell Park Cancer Institute | 2015-05-15 |
| Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02393755) | Roswell Park Cancer Institute | 2015-05-08 |
| SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma (NCT02455557) | Roswell Park Cancer Institute | 2015-05-04 |
| Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT02414724) | Roswell Park Cancer Institute | 2015-05-01 |
| Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation (NCT02531906) | Roswell Park Cancer Institute | 2015-04-24 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer (NCT02048943) | Roswell Park Cancer Institute | 2015-03-01 |
| Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment (NCT02287727) | Roswell Park Cancer Institute | 2015-03-01 |
| Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer (NCT02227940) | Roswell Park Cancer Institute | 2015-01-08 |
| Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT02159950) | Roswell Park Cancer Institute | 2015-01-01 |
| Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer (NCT02474095) | Roswell Park Cancer Institute | 2014-11-04 |
| Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer (NCT02170389) | Roswell Park Cancer Institute | 2014-10-14 |
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission (NCT02166905) | Roswell Park Cancer Institute | 2014-10-10 |